CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
Heejung Chae, Dok Hyun Yoon
Korean J Med. 2019;94(2):152-158.   Published online 2019 April 1    DOI: https://doi.org/10.3904/kjm.2019.94.2.152

Excel Download

Rapid and sustained response to Chimeric Antigen Receptor T cell therapy in double hit diffuse large B cell lymphoma
American Journal of Hematology. 2019;   Crossref logo
Link1 Link2 Link3

Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
The Korean Journal of Medicine. 2019;94(2):152-158   Crossref logo
Link1 Link2 Link3

653. Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
Molecular Therapy. 2013;21:S249   Crossref logo
Link1 Link2

651. Tumor Targeting Using CD19-Specific CAR (Chimeric Antigen Receptor) for B-Cell Lymphoma
Molecular Therapy. 2013;21:S248-S249   Crossref logo
Link1 Link2

Corrigendum: Dawn of chimeric antigen receptor T cell therapy in non-Hodgkin Lymphoma
Advances in Cell and Gene Therapy. 2019;2(1):e44   Crossref logo
Link1 Link2

THE ROLES OF PET/CT IN PREDICTING THE PROGNOSIS OF CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY TREATED PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
Hematological Oncology. 2019;37:504-504   Crossref logo
Link1 Link2

Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
Cancer Gene Therapy. 2019;26(7-8):248-255   Crossref logo
Link1 Link2 Link3

Rapid tumor regression from PD-1 inhibition after anti-CD19 chimeric antigen receptor T-cell therapy in refractory diffuse large B-cell lymphoma
Bone Marrow Transplantation. 2019;   Crossref logo
Link1 Link2 Link3

Radiotherapy in Combination with Chimeric Antigen Receptor T Cell Therapy Is a Safe and Promising Approach in Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with High Tumor Burden
International Journal of Radiation Oncology*Biology*Physics. 2019;105(1):S67   Crossref logo
Link1 Link2

750. Anti-Tumor Effects of Anti-CD20 Chimeric Antigen Receptor Therapy in Canine B Cell Lymphoma Patients
Molecular Therapy. 2016;24:S296   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Med has participated in CrossRef Text and Data Mining service since September 11, 2015.